JTCS Speed Up Your Browser
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Michael A. Maddaus
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rubins, J. B.
Right arrow Articles by Niewoehner, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rubins, J. B.
Right arrow Articles by Niewoehner, D. E.

J Thorac Cardiovasc Surg 1998;116:412-416
© 1998 Mosby, Inc.


General Thoracic Surgery

Serum carcinoembryonic antigen as an adjunct to preoperative stagingof lung cancer

Jeffrey B. Rubins, MDa, Jordan Dunitz, MDa, Hanna B. Rubins, MD, MPHb, Michael A. Maddaus, MDc, Dennis E. Niewoehner, MDa

Supported by the Veterans Affairs Department of Research.

Received for publication Nov. 24, 1997. Revisions requested Jan. 30, 1998; revisions received May 14, 1998. Accepted for publication June 3, 1998. Address for reprints: Jeffrey B. Rubins, MD, Pulmonary (111N), VAMedical Center, One Veterans Dr, Minneapolis, MN 55417.

Objective: To determine whethermeasurement of preoperative serum carcinoembryonic antigen concentrations addsuseful prognostic data to current preoperative staging of lung cancer bycomputed tomography, bronchoscopy, and mediastinoscopy.
Methods: A prospective cohort study of 130 consecutivepatients was evaluated for suspected lung cancer from July 1991 through December1992 at a university-affiliated Veterans Affairs Medical Center. Serumconcentrations of carcinoembryonic antigen were measured before diagnosis,staging, or resection of cancer.
Results:Malignant disease was diagnosed by bronchoscopy, needle biopsy, mediastinoscopy,or resection in 111 of 130 patients. In the 50 patients undergoing resectionwith curative intent, multivariate analysis indicated that carcinoembryonicantigen was a significant predictor of survival independent of patient age,pathologic stage, histologic type, and tumor size (P =.0357).
Conclusions: Elevated preoperativeserum concentrations of carcinoembryonic antigen predict a poor prognosis forlung cancer independent of other conventional staging parameters and have anadjunctive role in the staging of lung cancer. (J Thorac Cardiovasc Surg1998;116:412-6)




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
K. Matsuoka, S. Sumitomo, N. Nakashima, D. Nakajima, and N. Misaki
Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer
Eur. J. Cardiothorac. Surg., September 1, 2007; 32(3): 435 - 439.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
R. Fukai, Y. Sakao, M. Sakuraba, S. Oh, K. Shiomi, S. Sonobe, Y. Saitoh, and H. Miyamoto
The prognostic value of carcinoembryonic antigen in T1N1M0 and T2N1M0 non-small cell carcinoma of the lung
Eur. J. Cardiothorac. Surg., September 1, 2007; 32(3): 440 - 444.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Tomita, T. Shimizu, Y. Matsuzaki, M. Hara, T. Ayabe, and T. Onitsuka
Prognostic Significance of Carcinoembryonic Antigen Level in Pleural Lavage Fluid for Patients With Lung Adenocarcinoma
Ann. Thorac. Surg., July 1, 2005; 80(1): 276 - 281.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
Y. Sakao, S. Tomimitsu, Y. Takeda, M. Natsuaki, and T. Itoh
Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma
Eur. J. Cardiothorac. Surg., April 1, 2004; 25(4): 520 - 522.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
N. Sawabata, H. Hirano, M. Inoue, Y. Okumura, H. Asada, S.-i. Takeda, and H. Maeda
Immunohistochemical analysis of resectedclinical Stage I pulmonary adenocarcinomas withhigh preoperative levels of serumcarcinoembryonic antigen
Ann. Thorac. Surg., July 1, 2003; 76(1): 203 - 207.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
T. Aoki, M. Tsuchida, T. Watanabe, T. Hashimoto, T. Koike, T. Hirono, and J.-i. Hayashi
Surgical strategy for clinical stage I non-small cell lung cancer in octogenarians
Eur. J. Cardiothorac. Surg., April 1, 2003; 23(4): 446 - 450.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
N. Sawabata, M. Ohta, S.-i. Takeda, H. Hirano, Y. Okumura, H. Asada, and H. Maeda
Serum carcinoembryonic antigen level in surgically resected clinical stage i patients with non-small cell lung cancer
Ann. Thorac. Surg., July 1, 2002; 74(1): 174 - 179.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Takamochi, K. Nagai, J. Yoshida, K. Suzuki, Y. Ohde, M. Nishimura, K. Takahashi, and Y. Nishiwaki
THE ROLE OF COMPUTED TOMOGRAPHIC SCANNING IN DIAGNOSING MEDIASTINAL NODE INVOLVEMENT IN NON-SMALL CELL LUNG CANCER
J. Thorac. Cardiovasc. Surg., June 1, 2000; 119(6): 1135 - 1140.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
K. Takamochi, K. Nagai, K. Suzuki, J. Yoshida, Y. Ohde, and Y. Nishiwaki
Clinical Predictors of N2 Disease in Non-small Cell Lung Cancer
Chest, June 1, 2000; 117(6): 1577 - 1582.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1998 by The American Association for Thoracic Surgery.